Navigation Links
Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
Date:6/27/2012

HAYWARD, Calif., June 27, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced results from the Phase 2b PEARL-SC clinical study in patients with systemic lupus erythematosus.The purpose of the PEARL-SC study was to identify an effective and safe dose for future phase 3 clinical studies and explore key inclusion criteria and clinical endpoints in an effort to maximize differentiation of blisibimod from currently available therapies.  The 200mg weekly subcutaneous dose of blisibimod demonstrated a strong trend in improved clinical response as early as week 16 (p= 0.14), at the primary endpoint (p=0.15) and throughout week 44 including a statistically significant improvement at week 20 versus placebo (p=0.02).

In a predefined phase 3 target population of severely ill, seropositive lupus patients, defined as SELENA-SLEDAI ≥10 and receiving background corticosteroid medication, a more pronounced effect was seen in the 200mg weekly dose group demonstrating a 13.8% treatment difference compared to placebo at 24 weeks.  In this subgroup, planned for phase 3 studies, separation of clinical response occurred as early as week 8 and was also sustained through week 44.  Results from the 200mg weekly group are presented in Table 1.

"The extensive data in the target severe population from our Phase 2 clinical program supports the initiation of a much smaller yet differentiated Phase 3 registration plan with the selected dose of blisibimod in patients with severe systemic lupus erythematosus.  We have prospectively demonstrated for the first time the possibility for a subcutaneously administered BAFF inhibitor to be used in the treatment of a severe lupus population.  The subgroup of severe pat
'/>"/>

SOURCE Anthera Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
2. Anthera Announces First Quarter 2012 Financial Report and Conference Call
3. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
4. Neuralstem Updates ALS Stem Cell Trial Progress
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
7. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
8. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
9. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
10. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ), ... will present at the Deutsche Bank 38 th Annual ... a.m. (ET). A live webcast of BD,s ... www.bd.com/investors and will be available for replay through ... BD is a leading global medical technology company that ...
(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately.  Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2
... to a new market research report " ... (ICs, Thermostat, Thermistor, Resistive Temperature Detectors (RTDs), Thermocouple) & ... " published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the ... was $3.27 billion and is expected to reach $4.51 ...
... 29, 2012  Cempra, Inc. (NASDAQ: CEMP ) ... and chief executive officer, will present at the Cowen ... a.m. EST, March 6, 2012, at The Boston Marriott ... overview of the company,s two leading antibiotic clinical programs, ...
Cached Medicine Technology:MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 2MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 3Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference 2
(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...
(Date:5/25/2013)... viruses and parasites that affect both dogs and humans, ... than can result in liver or kidney failure -- ... veterinarian. These germs could be found in ... Susan Nelson, a clinical associate professor at Kansas State ... can be fatal, even with treatment," she said in ...
(Date:5/25/2013)... 25, 2013 Radius Engineering International ... company in the US and has been building ... over 35 years. M.E. and President, Walton McCarthy, ... NBC Weapon Fundamentals and Shelter Engineering Standards, Sixth ... on shelter engineering. McCarthy is considered the leading ...
(Date:5/25/2013)... 25, 2013 Absolute Surgical Specialists, serving Sun ... the NALA’s businesses throughout the country participating in Shop Local ... in the nationwide event as he understands what military families ... the Army. He said, “I wanted to give something back, ... but I live here too.” , Shop Local for a ...
(Date:5/25/2013)... May 25, 2013 The latest ... from irritable bowel syndrome (IBS) to bloating, constipation, ... the most long-lasting, embarrassing, frustrating and difficult health ... for digestive health have provided a cure ... many factors contributing to digestive health issues, a ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
... ... Studies offers Professional Certificates in Project Management both online and in the classroom starting ... , ... 19, 2009 -- San Diego State University,s College of Extended Studies will offer spring ...
... ... operational efficiencies. , ... Charlotte, NC (Vocus) November 19, 2009 -- Morehead, the human capital research firm, will ... webinar will be broadcast on Thursday, December 10, 2009 at 1:00 p.m. EST. ...
... , STAMFORD, Conn., Nov. 18 AmeriCares and ... the Philippines, where thousands of people are still reeling from ... Floodwaters from Typhoon Ketsana and other storms have been slow ... tens of thousands still homeless and living in crowded evacuation ...
... , KING OF PRUSSIA, Pa., Nov. 18 ... that its Board of Directors has declared a two for one ... on December 15, 2009 to shareholders of record as of December ... pro rata basis. The Board,s decision should improve liquidity and trading ...
... N.J., Nov. 18 GettingHired, LLC , ... disabilities, announced today that it has secured $3 million of ... disability employment portal in the USA as well as final ... work initiative supporting the long term disability and workers, compensation ...
... , WASHINGTON, Nov. 18 The ... TIME Magazine Foreign Correspondent Vivienne Walt with its ... meeting. , "Ms. Walt,s work has unveiled the need ... to improve healthcare around the world," said Thomas Wellems, MD, ...
Cached Medicine News:Health News:San Diego State Offers Project Management Programs Beginning in January 2Health News:Morehead Presents Webinar on "How Physician Attitudes Impact Hospital Goals " 2Health News:AmeriCares and Boeing Deliver Emergency Relief Supplies to the Philippines 2Health News:GettingHired Announces Additional Funding for Continued Growth as Well as R&D of New Product for Long Term Disability and Workers' Comp. 2Health News:GettingHired Announces Additional Funding for Continued Growth as Well as R&D of New Product for Long Term Disability and Workers' Comp. 3Health News:Acclaimed American Journalist Awarded Excellence In Journalism by American Society of Tropical Medicine and Hygiene 2
... C-Peptide is devoid of any biological activity ... the structural integrity of insulin. Although insulin ... in equimolar concentrations, fasting levels of C-Peptide ... insulin owing to the longer half-life of ...
Inquire...
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use....
... Zeus Scientific, Inc. Measles test ... qualitative and quantitative detection of ... by the indirect fluorescent antibody ... determine or confirm recent infection ...
Medicine Products: